SABA, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 2.810
EU - Europa 1.688
AS - Asia 986
SA - Sud America 126
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.684
Nazione #
US - Stati Uniti d'America 2.784
SG - Singapore 438
UA - Ucraina 394
SE - Svezia 232
IE - Irlanda 195
TR - Turchia 194
RU - Federazione Russa 189
DE - Germania 177
DK - Danimarca 151
IT - Italia 131
CN - Cina 128
HK - Hong Kong 124
BR - Brasile 113
FI - Finlandia 95
KR - Corea 80
FR - Francia 62
CI - Costa d'Avorio 51
GB - Regno Unito 29
MA - Marocco 13
CA - Canada 12
MX - Messico 12
RO - Romania 6
AT - Austria 5
BD - Bangladesh 5
BE - Belgio 5
BG - Bulgaria 4
CL - Cile 4
AR - Argentina 3
EC - Ecuador 3
IN - India 3
IR - Iran 3
PL - Polonia 3
AL - Albania 2
EU - Europa 2
IQ - Iraq 2
LT - Lituania 2
NL - Olanda 2
OM - Oman 2
TN - Tunisia 2
AU - Australia 1
AZ - Azerbaigian 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
IS - Islanda 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PY - Paraguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 5.684
Città #
Jacksonville 395
Chandler 350
Fairfield 251
Singapore 234
Dublin 195
Boardman 183
Wilmington 142
Ashburn 134
Hong Kong 121
Woodbridge 120
Seattle 111
New York 110
Houston 104
Lawrence 79
Princeton 79
San Mateo 79
Moscow 73
Ann Arbor 69
Cambridge 69
Abidjan 51
Turin 44
Beijing 30
Des Moines 20
San Diego 20
The Dalles 14
Los Angeles 13
Shanghai 11
Izmir 10
Munich 10
Wuhan 10
Mexico City 9
São Paulo 9
Helsinki 8
London 8
Turku 8
Buffalo 7
Falls Church 7
Guangzhou 7
Norwalk 6
Nuremberg 6
Brussels 5
Kilburn 5
Belo Horizonte 4
Dallas 4
Ottawa 4
Palermo 4
Venice 4
Wuxi 4
Aracaju 3
Atlanta 3
Campinas 3
Campobasso 3
Contagem 3
Jiaxing 3
San Jose 3
Santa Clara 3
Stockholm 3
Warsaw 3
Washington 3
Augusta 2
Boston 2
Brasília 2
Brooklyn 2
Caxias do Sul 2
Charlotte 2
Chicago 2
Denver 2
Dhaka 2
Duque de Caxias 2
Foligno 2
Guayaquil 2
Hangzhou 2
Ipatinga 2
Las Vegas 2
Manchester 2
Marche 2
Montemarciano 2
Montreal 2
Muscat 2
North Bergen 2
Parauapebas 2
Paris 2
Pato Branco 2
Porto Alegre 2
Pune 2
Redmond 2
Rio Grande 2
Rio de Janeiro 2
Serra 2
Shenzhen 2
Simi Valley 2
Tirana 2
Tunis 2
'Ali as Salih 1
'Omer 1
Americana 1
Antakya 1
Araçatuba 1
Astana 1
Asunción 1
Totale 3.348
Nome #
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 218
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 192
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 148
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 139
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 103
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 91
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 91
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 90
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 90
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 88
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 87
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 87
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 83
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 83
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 82
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 82
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 82
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 79
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 79
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 79
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 78
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 77
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 77
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 77
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 76
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 76
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 75
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 75
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 75
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 75
Glyoxalase II and glutathione levels in rat liver mitochondria during cold storage in Euro-Collins and University of Wisconsin solutions 74
LL-37 protects rats against lethal gram-negative sepsis. 72
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 72
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 71
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 71
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 69
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 68
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 68
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 67
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 67
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 67
The bovine antimicrobial peptide BMAP-28 reduces lethality due to bacterial cell wall components in mouse models of staphylococcal sepsis 66
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 66
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 65
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 65
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to multiresistant Pseudomonas aeruginosa strain 64
Potential therapeutic role of cationic peptides in three experimental models of septic shock 64
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 64
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 64
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 63
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 62
Mupirocin as prophylactic agent against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate Staphylococcus epidermidis vascular graft infection. 61
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 61
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 61
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 61
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 60
Polycationic peptides as prophylactic agents against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection 60
Potential therapeutic role of histatins derivative P-113D in experimental rat models of Pseudomonas sepsis 59
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 58
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 58
Therapeutic efficacy of the magainin analog MSI-78 in different intra-abdominal sepsis rat models 57
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 57
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 55
Valore prognostico dell'indice Apache II nell'impiego routinario preoperatorio in chirurgia generale maggiore 55
RNA III Inhibiting Peptide (RIP) inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus 54
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 54
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. 53
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 53
Interaction of antimicrobial peptide temporin L with lipopolisaccharide in vitro and in experimental rat models of Gram-negative septic shock. 52
Single-dose intraperitoneal magainins improve survival in a gram-negative pathogens septic shock rat model. 52
Temporin A as prophylactic agent against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection. 51
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 51
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 51
RNAIII inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated S. aureus infections 50
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine models of staphylococcal sepsis 50
Temporin A Soaking in Combination with Intraperitoneal Linezolid Prevents Vascular Graft Infection in a Subcutaneous Rat Pouch Model Infected with Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides 50
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. 49
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides 45
Temporin A alone and in combination with imipenem reduces lethality in mouse models of staphylococcal sepsis 45
1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients 3
CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins 1
Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: Relationship with inflammation (IL-6) and zinc 1
A novel Zip2 Gln/Arg/Leu codon 2 polymorphism is associated with carotid artery disease in aging 1
The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people 1
Totale 5.773
Categoria #
all - tutte 29.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020116 0 0 0 0 0 0 0 0 0 0 0 116
2020/20211.096 64 119 153 16 120 88 104 74 114 91 104 49
2021/2022583 51 122 0 27 3 54 15 30 35 92 24 130
2022/20231.040 106 114 91 81 91 106 0 50 286 7 84 24
2023/2024518 109 12 22 88 89 122 5 5 3 4 13 46
2024/20251.357 171 100 93 82 63 95 163 69 260 55 140 66
Totale 5.773